Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yasumi Kitahara
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of E3024, a Novel and Selective Dipeptidyl Peptidase-Iv Inhibitor, in Healthy Japanese Male Subjects: Rash Development in Men and Its Possible Mechanism
Pharmacology & Pharmacy
Related publications
Pharmacokinetics, Pharmacodynamics, and Tolerability of Verinurad, a Selective Uric Acid Reabsorption Inhibitor, in Healthy Japanese and Non-Asian Male Subjects
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Pharmacokinetics, Pharmacodynamics, and Safety of Peficitinib (ASP015K) in Healthy Male Caucasian and Japanese Subjects
Clinical Drug Investigation
Medicine
Pharmacology
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Empagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Healthy Japanese Subjects
Drug Metabolism and Pharmacokinetics
Pharmacology
Pharmaceutical Science
Pharmacokinetics and Tolerability of DA-8031, a Novel Selective Serotonin Reuptake Inhibitor for Premature Ejaculation in Healthy Male Subjects
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Pharmacokinetics, Pharmacodynamics, Tolerability and Safety of Single Doses of Bivalirudin in Healthy Chinese Subjects
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Comparison of the Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Healthy Japanese and Caucasian Subjects
Clinical Drug Investigation
Medicine
Pharmacology
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Anti-Cd38 Cytolytic Antibody TAK-079 in Healthy Subjects
British Journal of Clinical Pharmacology
Pharmacology
Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Pharmacokinetic and Pharmacodynamic Interactions Between Metformin and a Novel Dipeptidyl Peptidase-4 Inhibitor, Evogliptin, in Healthy Subjects
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
